A. Gutiérrez

发表

Actual Anti-TNF Trough Levels Relate to Serum IL-10 in Drug-Responding Patients With Crohn's Disease.

G. Rogler, J. González-Navajas, M. Scharl, 2019, Inflammatory bowel diseases.

Safety of Thiopurine Therapy in Inflammatory Bowel Disease: Long-term Follow-up Study of 3931 Patients

J. Mate, J. Gisbert, I. Ordás, 2013, Inflammatory bowel diseases.

Effectiveness of anti-TNFα drugs in patients with Crohn's disease who do not achieve remission with their first anti-TNFα agent.

J. Gisbert, X. Calvet, M. Chaparro, 2016, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Cytokine association with bacterial DNA in serum of patients with inflammatory bowel disease

R. Jover, P. Zapater, A. Gutiérrez, 2009, Inflammatory bowel diseases.

Anti-TNF-alpha loss of response is associated with a decreased percentage of FoxP3+ T cells and a variant NOD2 genotype in patients with Crohn’s disease

J. González-Navajas, P. Zapater, A. Gutiérrez, 2015, Journal of Gastroenterology.

Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapy

J. Gisbert, X. Calvet, I. Ordás, 2010, Gut.

Management and outcomes of patients with Crohn’s disease with first vs multiple surgeries: results from the PRACTICROHN study

J. Gisbert, A. Gutiérrez, C. Taxonera, 2019, Gastroenterology report.

Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on screening and treatment of tuberculosis infection in patients with inflammatory bowel disease

S. Riestra, A. Gutiérrez, C. Taxonera, 2021 .

Clinical characteristics, associated malignancies and management of primary sclerosing cholangitis in inflammatory bowel disease patients: A multicenter retrospective cohort study.

J. Gisbert, X. Calvet, M. Piqueras, 2019, Journal of Crohn's & colitis.

Post‐Operative Morbidity and Mortality of a Cohort of Steroid Refractory Acute Severe Ulcerative Colitis: Nationwide Multicenter Study of the GETECCU ENEIDA Registry

X. Calvet, I. Ordás, J. Panés, 2018, The American Journal of Gastroenterology.

Gut Bacterial DNA Translocation is an Independent Risk Factor of Flare at Short Term in Patients With Crohn’s Disease

G. Rogler, J. González-Navajas, M. Scharl, 2016, The American Journal of Gastroenterology.

Genetic association between CD96 locus and immunogenicity to anti-TNF therapy in Crohn’s disease

J. Gisbert, J. Panés, A. Julià, 2019, The Pharmacogenomics Journal.

Antimicrobial peptide response to blood translocation of bacterial DNA in Crohn's disease is affected by NOD2/CARD15 genotype

E. Holler, R. Jover, P. Zapater, 2011, Inflammatory bowel diseases.

Recommendations by the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the treatment of patients with inflammatory bowel disease associated with spondyloarthritis.

J. Gisbert, M. Chaparro, A. Gutiérrez, 2020 .

Hepatotoxicity Related to Paraquat and Diquat Absorption Through Intact Skin

P. Zapater, A. Gutiérrez, M. Pérez-Mateo, 2007, Digestive Diseases and Sciences.

Phenotypic concordance in familial inflammatory bowel disease (IBD). Results of a nationwide IBD Spanish database.

J. Gisbert, E. Cabré, A. Gutiérrez, 2014, Journal of Crohn's & colitis.

Clinical features, therapeutic requirements and evolution of patients with Crohn’s disease and upper gastrointestinal involvement (CROHNEX study)

M. Piqueras, L. Bujanda, A. Gutiérrez, 2021, Alimentary pharmacology & therapeutics.

Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study

J. Gisbert, F. Rodríguez‐Artalejo, X. Calvet, 2021, Journal of clinical medicine.

Early azathioprine therapy is no more effective than placebo for newly diagnosed Crohn's disease.

M. Sans, J. Panés, M. Piqueras, 2013, Gastroenterology.

Novel IL10 gene family associations with systemic juvenile idiopathic arthritis

C. Lewis, W. Thomson, P. Woo, 2006, Arthritis research & therapy.

Novel IL-10 gene family associations with systemic juvenile idiopathic arthritis (SJIA)

Fife, C. Lewis, W. Thomson, 2006 .

Novel IL-6 haplotypes and disease association

S. Humphries, P. Woo, A. Gutiérrez, 2005, Genes and Immunity.

Whipple’s disease diagnosed during anti-tumor necrosis factor alpha treatment: two case reports and review of the literature

J. Rosas, A. Gutiérrez, J. Ramos, 2015, Journal of Medical Case Reports.

Short and long‐term effectiveness and safety of vedolizumab in inflammatory bowel disease: results from the ENEIDA registry

J. Gisbert, M. Piqueras, M. Andreu, 2018, Alimentary pharmacology & therapeutics.

Addition of Granulocyte/Monocyte Apheresis to Oral Prednisone for Steroid-dependent Ulcerative Colitis: A Randomized Multicentre Clinical Trial

V. Annese, W. Reinisch, S. Danese, 2018, Journal of Crohn's & colitis.

Real‐world short‐term effectiveness of ustekinumab in 305 patients with Crohn’s disease: results from the ENEIDA registry

J. Gisbert, L. Bujanda, A. Gutiérrez, 2019, Alimentary pharmacology & therapeutics.

Observational study on the efficacy of adalimumab for the treatment of ulcerative colitis and predictors of outcome.

J. Gisbert, X. Calvet, J. Panés, 2013, Journal of Crohn's & colitis.

Evolution of the emotional impact in patients with early inflammatory bowel disease during and after Covid-19 lockdown

R. Jover, P. Zapater, A. Gutiérrez, 2022, Gastroenterología y Hepatología (English Edition).

Long‐term durability of response to adalimumab in Crohn's disease

J. Gisbert, J. Panés, M. Andreu, 2012, Inflammatory bowel diseases.

Incidence, Clinical Characteristics, and Management of Psoriasis Induced by Anti-TNF Therapy in Patients with Inflammatory Bowel Disease: A Nationwide Cohort Study

J. Gisbert, X. Calvet, M. Chaparro, 2016, Inflammatory bowel diseases.

Risk of colectomy in patients with ulcerative colitis under thiopurine treatment.

J. Gisbert, X. Calvet, M. Andreu, 2014, Journal of Crohn's & colitis.

Factors predicting response to hepatitis B vaccination in patients with inflammatory bowel disease.

J. Sánchez-Payá, E. de-Madaria, A. Gutiérrez, 2013, Vaccine.

Inflammatory bowel disease integral care units: Evaluation of a nationwide quality certification programme. The GETECCU experience

J. Gisbert, X. Calvet, J. Panés, 2021, United European gastroenterology journal.

Incidence and Management of Recurrence in Patients with Crohn's Disease Who Have Undergone Intestinal Resection: The Practicrohn Study

M. Mínguez, A. Gutiérrez, C. Taxonera, 2017, Inflammatory bowel diseases.

Early Use of Azathioprine Has a Steroid Sparing Effect on Recently Diagnosed Crohn's Disease Patients

J. Gisbert, M. Sans, F. Mearin, 2011 .

Clinical and Immunological Factors Associated with Recommended Trough Levels of Adalimumab and Infliximab in Patients with Crohn’s Disease

P. Zapater, A. Gutiérrez, L. Sempere, 2022, Frontiers in Pharmacology.

Prevalence and Factors Related to Hepatitis B and C in Inflammatory Bowel Disease Patients in Spain: A Nationwide, Multicenter Study

J. Gisbert, X. Calvet, J. Panés, 2009, The American Journal of Gastroenterology.

Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native Patients

J. Gisbert, X. Calvet, M. Piqueras, 2022, Frontiers in Medicine.

Effectiveness and safety of ustekinumab in ulcerative colitis: Real-world evidence from the ENEIDA registry

J. Gisbert, X. Calvet, M. Piqueras, 2021, Journal of Crohn's & colitis.

Perioperative management and early complications after intestinal resection with ileocolonic anastomosis in Crohn’s disease: analysis from the PRACTICROHN study

J. Barrio, A. Gutiérrez, M. Martín-Arranz, 2019, Gastroenterology report.

Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study

J. Gisbert, X. Calvet, J. Tosca, 2017, The American Journal of Gastroenterology.

Long-term Durability of Infliximab Treatment in Crohn's Disease and Efficacy of Dose “Escalation” in Patients Losing Response

J. Gisbert, J. Panés, M. Andreu, 2011, Journal of clinical gastroenterology.

Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients With Inflammatory Bowel Disease: Results From the Eneida Registry.

J. Gisbert, X. Calvet, M. Dominguez-Cajal, 2019, Inflammatory bowel diseases.

EFFECTIVENESS AND SAFETY OF THE SEQUENTIAL USE OF A SECOND AND THIRD ANTI-TNF AGENT IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: RESULTS FROM THE ENEIDA REGISTRY SHORT TITLE: Sequential use of anti-TNFs in IBD patients AUTHORS

Mariana, J. Gisbert, X. Calvet, 2020 .

Evolution of the emotional impact in patients with early inflammatory bowel disease during and after Covid-19 lockdown

R. Jover, P. Zapater, A. Gutiérrez, 2021, Gastroenterología y Hepatología.

Real‐world long‐term effectiveness of ustekinumab in Crohn's disease: results from the ENEIDA registry

X. Calvet, A. Gutiérrez, F. Mesonero, 2020, Alimentary pharmacology & therapeutics.

Granulocyte and monocyte apheresis in inflammatory bowel disease: The patients' point of view.

A. Gutiérrez, L. Sempere, D. Ginard, 2018, Gastroenterologia y hepatologia.

Intestinal permeability is increased in patients with advanced cirrhosis.

J. Aparicio, J. Casellas, P. Zapater, 2003, Hepato-gastroenterology.

Position statement. Recommendations of the Spanish group on Crohn’s disease and ulcerative colitis (GETECCU) on the treatment of strictures in Crohn’s disease

V. Sánchiz, A. Gutiérrez, Y. Zabana, 2022, Gastroenterología y Hepatología (English Edition).

Multicriteria Decision Analysis for Updating of Quality Indicators for Inflammatory Bowel Disease Comprehensive Care Units in Spain

X. Calvet, J. Panés, M. Chaparro, 2022, Journal of Crohn's & colitis.

Minimal hepatic encephalopathy and extrapyramidal signs in patients with cirrhosis

J. Aparicio, R. Jover, P. Zapater, 2003, American Journal of Gastroenterology.

Endocrine disruption in Crohn’s disease: Bisphenol A enhances systemic inflammatory response in patients with gut barrier translocation of dysbiotic microbiota products

Mariana F. Fernández, F. Tomás-Barberán, P. Zapater, 2021, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Bacterial Translocation as Inflammatory Driver in Crohn’s Disease

A. Gutiérrez, R. Linares, R. Francés, 2021, Frontiers in Cell and Developmental Biology.

Genetic susceptibility to increased bacterial translocation influences the response to biological therapy in patients with Crohn's disease

G. Rogler, J. González-Navajas, E. Holler, 2013, Gut.

Recommendations of the Spanish Working Group on Crohn’s Disease and Ulcerative Colitis (GETECCU) on pouchitis in ulcerative colitis. Part 1: Epidemiology, diagnosis and prognosis

J. Gisbert, E. Espin, M. Chaparro, 2019, Gastroenterología y Hepatología (English Edition).

Long-Term Efficacy and Safety of Cyclosporine in a Cohort of Steroid-Refractory Acute Severe Ulcerative Colitis Patients from the ENEIDA Registry (1989–2013): A Nationwide Multicenter Study

X. Calvet, I. Ordás, J. Panés, 2017, The American Journal of Gastroenterology.

Disease severity in familial cases of IBD.

J. Gisbert, X. Calvet, J. Panés, 2014, Journal of Crohn's & colitis.

Disease severity infamilial casesofIBD

X. Calvet, M. Andreu, A. Gutiérrez, 2014 .

A genome-wide association study on a southern European population identifies a new Crohn's disease susceptibility locus at RBX1-EP300

Jaume Bertranpetit, Fernando Muñoz, Maria Esteve, 2012, Gut.

A genome-wide association study identifies a novel locus at 6q22.1 associated with ulcerative colitis.

D. Absher, R. Myers, J. Gisbert, 2014, Human molecular genetics.

Switching to a second thiopurine in adult and elderly patients with inflammatory bowel disease: a nationwide study from the ENEIDA registry.

J. Gisbert, X. Calvet, S. Riestra, 2020, Journal of Crohn's & colitis.

Antitumor Necrosis Factor Agents to Treat Endoscopic Postoperative Recurrence of Crohn's Disease: A Nationwide Study With Propensity-Matched Score Analysis

L. Bujanda, J. Barrio, A. Gutiérrez, 2020, Clinical and translational gastroenterology.

Impact of Biological Agents on Postsurgical Complications in Inflammatory Bowel Disease: A Multicentre Study of Geteccu

J. Gisbert, I. Bastón-Rey, M. Chaparro, 2021, Journal of clinical medicine.

Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on pouchitis in ulcerative colitis. Part 2: Treatment

F. Guarner, J. Gisbert, E. Espin, 2020 .

Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on pouchitis in ulcerative colitis. Part 1: Epidemiology, diagnosis and prognosis.

J. Gisbert, E. Espin, M. Chaparro, 2019, Gastroenterologia y hepatologia.

Nationwide COVID-19-EII Study: Incidence, Environmental Risk Factors and Long-Term Follow-Up of Patients with Inflammatory Bowel Disease and COVID-19 of the ENEIDA Registry

J. Gisbert, M. Piqueras, A. Lucendo, 2022, Journal of clinical medicine.

Risk Factors for COVID-19 in Inflammatory Bowel Disease: A National, ENEIDA-Based Case–Control Study (COVID-19-EII)

M. Piqueras, L. Bujanda, D. Busquets, 2022, Journal of clinical medicine.

How to Optimize Treatment With Ustekinumab in Inflammatory Bowel Disease: Lessons Learned From Clinical Trials and Real-World Data

A. Gutiérrez, I. Rodríguez-Lago, 2021, Frontiers in Medicine.

Food groups associated with immune-mediated inflammatory diseases: a Mendelian randomization and disease severity study

J. Gisbert, J. Nolla, F. Vanaclocha, 2021, European Journal of Clinical Nutrition.

Real-World Evidence of Tofacinitib in Ulcerative Colitis: Short-Term and Long-Term Effectiveness and Safety.

J. Gisbert, X. Calvet, M. Piqueras, 2023, The American journal of gastroenterology.

Brain edema and inflammatory activation in bile duct ligated rats with diet‐induced hyperammonemia: A model of hepatic encephalopathy in cirrhosis

Omar Cauli, Ricardo Insausti, Miguel Pérez-Mateo, 2006, Hepatology.

Clinical Outcomes of Golimumab as First, Second or Third Anti-TNF Agent in Patients with Moderate-to-Severe Ulcerative Colitis

J. Gisbert, D. Busquets, A. Gutiérrez, 2017, Inflammatory bowel diseases.

Identification of risk loci for Crohn's disease phenotypes using a genome-wide association study.

Jaume Bertranpetit, Richard M Myers, Fernando Muñoz, 2015, Gastroenterology.

Diagnostic Performance of the Simple Clinical Colitis Activity Index Self-Administered Online at Home by Patients With Ulcerative Colitis: CRONICA-UC Study

J. Gisbert, X. Calvet, J. Panés, 2016, The American Journal of Gastroenterology.

Information resources used by patients with inflammatory bowel disease: Satisfaction, expectations and information gaps.

E. Torrella, M. Mínguez, A. Gutiérrez, 2015, Gastroenterologia y hepatologia.

Gender Biases and Diagnostic Delay in Inflammatory Bowel Disease: Multicenter Observational Study.

R. Jover, P. Zapater, A. Gutiérrez, 2023, Inflammatory bowel diseases.

Resumption of activity in gastroenterology departments. Recommendations by SEPD, AEEH, GETECCU and AEG☆

R. Andrade, J. Iglesias-Garcia, F. Jorquera, 2020, Gastroenterología y Hepatología (English Edition).

Corrigendum: Diagnostic Performance of the Simple Clinical Colitis Activity Index Self-Administered Online at Home by Patients With Ulcerative Colitis: CRONICA-UC Study

J. Gisbert, X. Calvet, J. Panés, 2016, The American Journal of Gastroenterology.

Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on pouchitis in ulcerative colitis. Part 2: Treatment.

F. Guarner, J. Gisbert, E. Espin, 2020, Gastroenterologia y hepatologia.

Effectiveness of a Multicomponent Group Psychological Intervention Program in Patients with Inflammatory Bowel Disease: A Randomized Trial

R. Jover, P. Zapater, A. Gutiérrez, 2021, International journal of environmental research and public health.

Clinical significance of extrapyramidal signs in patients with cirrhosis.

R. Jover, P. Zapater, A. Gutiérrez, 2003, Journal of hepatology.

Genetic association between CD96 locus and immunogenicity to anti-TNF therapy in Crohn’s disease

J. Gisbert, J. Panés, A. Julià, 2019, The Pharmacogenomics Journal.

Low adherence to colonoscopy in the screening of first-degree relatives of patients with colorectal cancer

Antoni Castells, Xavier Llor, Luis Bujanda, 2007, Gut.

Gut Microbiota Dysbiosis Is Associated with Inflammation and Bacterial Translocation in Mice with CCl4-Induced Fibrosis

Y. Sanz, P. Zapater, A. Gutiérrez, 2011, PloS one.

Long-Term Outcomes of Biological Therapy in Crohn's Disease Complicated With Internal Fistulizing Disease: BIOSCOPE Study From GETECCU

J. Gisbert, X. Calvet, M. Piqueras, 2021, American Journal of Gastroenterology.

Granulocyte–monocyte apheresis: an alternative combination therapy after loss of response to anti-TNF agents in ulcerative colitis

D. Arjona, U. Aguirre, A. Gutiérrez, 2019, Scandinavian journal of gastroenterology.

Minimal hepatic encephalopathy and extrapyramidal signs in patients with cirrhosis.

J. Aparicio, R. Jover, P. Zapater, 2003 .

Idiopathic acute pancreatitis in patients with inflammatory bowel disease: A multicenter cohort study.

S. Riestra, A. Gutiérrez, J. Cameo, 2019, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

W1193 Safety of Thiopurine Therapy in Inflammatory Bowel Disease (IBD): Long-Term Follow-up Study of 3,900 Patients

J. Gisbert, I. Ordás, E. Cabré, 2010 .

Relationship between minimal hepatic encephalopathy and extrapyramidal signs in cirrhotic patients

J. Aparicio, R. Jover, P. Zapater, 2003 .

OP034 The initiation of thiopurines in elderly patients with inflammatory bowel disease is associated with an increased risk of adverse effects: a case–control study of the ENEIDA registry

J. Gisbert, X. Calvet, J. Panés, 2018 .

Recomendaciones del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU) sobre el cribado y tratamiento de la infección tuberculosa en pacientes con enfermedad inflamatoria intestinal

S. Riestra, A. Gutiérrez, C. Taxonera, 2020, Gastroenterología y Hepatología.